missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human SERC2 Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (77%), Rat (77%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-52233 (PA5-52233. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
SERINC2 (Serine Incorporator 2) is a Protein Coding gene. Diseases associated with SERINC2 include Rapp-Hodgkin Syndrome and Alcohol Dependence. Among its related pathways are Viral mRNA Translation and Metabolism. Gene Ontology (GO) annotations related to this gene include L-serine transmembrane transporter activity. An important paralog of this gene is SERINC1. [GeneCards]
Specifications
Specifications
| Accession Number | Q96SA4 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 347735 |
| Name | Human SERC2 Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 2310004K20Rik; AW121759; FKSG84; PRO0899; Serinc2; Serine incorporator 2; TDE2; TDE2L; tumor differentially expressed protein 2; Tumor differentially expressed protein 2-like; UNQ263/PRO300 |
| Common Name | SERC2 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction